DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Ychou M, Raoul J, Douillard J et al. , for the GI Group of the FNCLCC and the FFCD
A phase III randomized trial of LV5FU2+CPT-11 vs. LV5FU2 alone in adjuvant high risk colon cancer (FNCLCC Accord02 / FFCD9802).
Journal of Clinical Oncology 2005; ASCO Annual Meeting Proceedings 2005
23: Abstract 3502 (Suppl 16, Part I of II):
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.